Interleukin-1/6 Blockade for the Treatment of Severe Steroid-Refractory BNT162b2 Vaccine-Induced Adult-Onset Still’s Disease

Interleukin-1/6 Blockade for the Treatment of Severe Steroid-Refractory BNT162b2 Vaccine-Induced Adult-Onset Still’s Disease

Introduction: Several immune-mediated side effects have been reported with COVID-19 vaccines, including myocarditis. Case description: A 27-year-old woman with a past medical history of mild COVID-19, developed adult-onset Still’s disease (AOSD) with salmon-pink flagellate erythema, polyarthritis,...

Full description

Bibliographic Details
Main Authors: Benjamin Hugues, Hakim Ben Amer, Floriane Bril, Matthieu Groh, Florent Huang
Format: Article
Language:English
Published: SMC MEDIA SRL 2022-08-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
adult-onset still’s disease
myocarditis
covid-19
vaccines
biological therapies
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/3469

Internet

https://www.ejcrim.com/index.php/EJCRIM/article/view/3469

Similar Items